Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01323348 · ClinicalTrials.gov registry record · Phase 3
Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control
A Phase 3 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,875
- Enrollment target
NCT01323348: Completed Phase 3 study, sponsored by Jaeb Center for Health Research.
NCT01323348 is a Phase 3 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 1,875 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (143% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01323348, a Phase 3 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,875 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether glycemic control (assessed with HbA1c measurement) in individuals with type 1 or type 2 diabetes can be improved with a point-of-care measurement of HbA1c in the ophthalmologist's office combined with a personalized risk assessment for diabetic retinopathy and other complications of diabetes.
Primary Outcome
Mean change in HbA1c from baseline to 12 months in intervention versus control for study participants being seen for standard care more frequently than every 12 months
Interventions
- BEHAVIORAL Diabetes Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,875 participants |
| Start Date | 2011-10 |
| Est. Completion | 2015-01 |
| Phase | Phase 3 |
What the finished NCT01323348 record still lists
NCT01323348 is an interventional study that assigns participants to a tested intervention. Its 1,875 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (143% higher).
The record links to 0 conditions, and to 1 intervention - of which Diabetes Education is the first listed.
NCT01323348 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01323348 about?
NCT01323348 is a clinical study titled "Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control". The purpose of this study is to assess whether glycemic control (assessed with HbA1c measurement) in individuals with type 1 or type 2 diabetes can be improved with a point-of-care measurement of HbA1c in the ophthalmologist's office combined with a personalized risk assessment for diabetic retinopa...
What is the current status of trial NCT01323348?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,875 participants. The study started on 2011-10. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01323348?
The interventions under investigation include: Diabetes Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01323348?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01323348's enrollment target sits among peer trials
1,875 113th of 2000 higher than 1,887 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05675410 · 1,875 participants · Phase 3
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- NCT06891898 · 1,875 participants
The iLet Experience Study
- NCT07356089 · 1,875 participants
Twiist Postmarket Surveillance Study for Type 1 Diabetes
- NCT07203313 · 1,872 participants · NA
Evaluation of Aim to Play, a User-Friendly Digital Application for Teacher Skills Training and Physical Education Activities for 3-5 Grade Students
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia